Second generation BTK inhibitors impair the anti‐fungal response of macrophages and neutrophils
Open Access
- 8 April 2020
- journal article
- letter
- Published by Wiley in American Journal of Hematology
- Vol. 95 (7), E174-E178
- https://doi.org/10.1002/ajh.25816
Abstract
No abstract availableFunding Information
- Consejo Nacional de Investigaciones Científicas y Técnicas
This publication has 8 references indexed in Scilit:
- Fungal Infections with Ibrutinib and Other Small-Molecule Kinase InhibitorsCurrent Fungal Infection Reports, 2019
- Ibrutinib induces multiple functional defects in the neutrophil response against Aspergillus fumigatusHaematologica, 2019
- Effect of the BTK inhibitor ibrutinib on macrophage- and γδ T cell-mediated response against Mycobacterium tuberculosisBlood Cancer Journal, 2018
- Ibrutinib blocks Btk-dependent NF-κB and NFAT responses in human macrophages during Aspergillus fumigatus phagocytosisBlood, 2018
- Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysisHaematologica, 2018
- Acalabrutinib (ACP-196): A Covalent Bruton Tyrosine Kinase Inhibitor with a Differentiated Selectivity and In Vivo Potency ProfileJournal of Pharmacology and Experimental Therapeutics, 2017
- The specific Bruton tyrosine kinase inhibitor acalabrutinib (ACP-196) shows favorable in vitro activity against chronic lymphocytic leukemia B cells with CD20 antibodiesHaematologica, 2017
- Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemiaOncotarget, 2016